Dr Reddys Laboratories receives EIR report for Srikakulam formulation plant Unit II

Explore Business Standard
Associate Sponsors
Co-sponsor

From USFDA
Dr Reddys Laboratories has received an Establishment Inspection Report (EIR) from the US FDA, for the Company's Formulation Srikakulam Plant (SEZ) Unit II, Andhra Pradesh.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Sep 21 2017 | 10:00 AM IST